HCA Healthcare, Inc. $HCA Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,506 shares of the company’s stock after selling 1,919 shares during the period. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $7,461,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare in the second quarter worth about $27,000. Clearstead Trust LLC raised its position in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Harbor Capital Advisors Inc. raised its holdings in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in HCA Healthcare in the second quarter valued at $40,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Down 1.4%

Shares of NYSE HCA opened at $472.40 on Friday. The firm has a market cap of $107.80 billion, a price-to-earnings ratio of 18.26, a price-to-earnings-growth ratio of 1.32 and a beta of 1.36. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $520.00. The company’s 50-day simple moving average is $479.87 and its 200-day simple moving average is $427.05.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Shareholders of record on Monday, December 15th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent research reports. UBS Group upped their target price on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. The Goldman Sachs Group increased their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Finally, Sanford C. Bernstein restated a “market perform” rating and issued a $503.00 price target on shares of HCA Healthcare in a research note on Tuesday. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $485.95.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is among the first health systems to access OpenAI’s new healthcare programs — a move that could drive clinical efficiency, faster workflow automation and potential cost savings if deployed broadly across HCA’s network. HCA Healthcare among first to access OpenAI’s new health care programs
• Positive Sentiment: OpenAI launched ChatGPT for Healthcare at several large systems — broader industry adoption reduces implementation risk and can accelerate HCA’s rollout benefits (clinical decision support, patient triage, revenue-cycle automation). OpenAI launches ChatGPT for Healthcare at several large health systems
• Positive Sentiment: HCA and AdventHealth are expanding ER footprints in Florida — inorganic/greenfield capacity additions should help volume growth and market share in a high-margin service line. HCA, AdventHealth expand Florida ER footprints
• Positive Sentiment: A new emergency facility opened in Arlington — incremental capacity and local access that can lift admissions and outpatient revenues. New emergency health facility opens in Arlington
• Positive Sentiment: HCA Florida Capital Hospital and UCF launched a medical residency program — strengthens physician pipeline and could reduce staffing pressures/costs over time. HCA Florida Capital Hospital, UCF create new medical residency program
• Positive Sentiment: An analyst raised HCA’s price target to $520 — a bullish signal that supports upside in the medium term if execution and margins track. HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00
• Neutral Sentiment: HCA Georgia hospital named a new CFO — routine executive hire that supports local operations but is not material company‑wide. HCA Georgia hospital taps CFO
• Neutral Sentiment: HCA rolled out a “Talk to a nurse for free” service — positive PR and access initiative but limited immediate financial impact. HCA says: ‘Talk to a nurse for free’
• Negative Sentiment: CEO exit after nine months at an HCA Virginia behavioral health hospital — leadership turnover can signal integration or operational issues in a growing behavioral-health segment. HCA Virginia behavioral health hospital CEO exits after 9 months
• Negative Sentiment: A MarketWatch note flagged HCA’s relative underperformance versus peers on a recent trading day — highlights near‑term downside risk if investors rotate into other healthcare names. HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.